インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2024-01-16 | BAROLDI, JOSEPH | EVP, Chief Business Officer | 普通株式 | 購入 | 3,688 | $0.00 |
| 2024-01-16 | BAROLDI, JOSEPH | EVP, Chief Business Officer | 普通株式 | 購入 | 1,353 | $0.00 |
| 2024-01-16 | BAROLDI, JOSEPH | EVP, Chief Business Officer | 譲渡制限付株式ユニット | 売却 | 3,688 | $0.00 |
| 2024-01-16 | CADORET-MANIER, ONAIZA | EVP, Chf GL Pdt Str & Oper Ofc | 譲渡制限付株式ユニット | 売却 | 15,062 | $0.00 |
| 2024-01-16 | CADORET-MANIER, ONAIZA | EVP, Chf GL Pdt Str & Oper Ofc | 普通株式 | 購入 | 15,062 | $0.00 |
| 2024-01-16 | SWAYZE, ERIC | EVP Research | 普通株式 | 購入 | 17,069 | $0.00 |
| 2024-01-16 | SWAYZE, ERIC | EVP Research | 普通株式 | 購入 | 21 | $0.00 |
| 2024-01-16 | SWAYZE, ERIC | EVP Research | 譲渡制限付株式ユニット | 売却 | 17,069 | $0.00 |
| 2024-01-16 | SWAYZE, ERIC | EVP Research | 譲渡制限付株式ユニット | 売却 | 21 | $0.00 |
| 2024-01-16 | SCHNEIDER, EUGENE | EVP, Chf Clinical Develop Ofcr | 普通株式 | 購入 | 15,162 | $0.00 |
| 2024-01-16 | SCHNEIDER, EUGENE | EVP, Chf Clinical Develop Ofcr | 譲渡制限付株式ユニット | 売却 | 15,162 | $0.00 |
| 2024-01-16 | MONIA, BRETT P | Director, Chief Executive Officer | 譲渡制限付株式ユニット | 売却 | 68,084 | $10.00 |
| 2024-01-16 | HOUGEN, ELIZABETH L | EVP, Finance & CFO | 普通株式 | 購入 | 22,487 | $0.00 |
| 2024-01-16 | HOUGEN, ELIZABETH L | EVP, Finance & CFO | 譲渡制限付株式ユニット | 売却 | 22,487 | $0.00 |
| 2024-01-16 | GEARY, RICHARD S | EVP, Chief Development Officer | 普通株式 | 購入 | 19,852 | $0.00 |
| 2024-01-16 | O'NEIL, PATRICK R. | EVP CLO & General Counsel | 普通株式 | 購入 | 20,641 | $0.00 |
| 2024-01-16 | GEARY, RICHARD S | EVP, Chief Development Officer | 譲渡制限付株式ユニット | 売却 | 19,852 | $0.00 |
| 2024-01-16 | BENNETT, C FRANK | EVP, Chief Scientific Officer | 普通株式 | 購入 | 18,314 | $0.00 |